This page will host Events plug-in for all Clarion and trade events.

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

3.434 -0.046 (-1.33%)

Streaming Delayed Price Updated: 3:01 PM EDT, Apr 28, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	5,991,350
Open	3.430
Bid (Size)	3.430 (29,100)
Ask (Size)	3.440 (62,000)
Prev. Close	3.480
Today's Range	3.380 - 3.495
52wk Range	2.800 - 7.180
Shares Outstanding	168,425,907
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Recursion to Participate in Upcoming Investor Conferences

April 07, 2026

From Recursion Pharmaceuticals

Via GlobeNewswire

Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine

April 06, 2026

In a move that has sent shockwaves through both the pharmaceutical and technology sectors, Eli Lilly and Company (NYSE: LLY) announced today, April 6, 2026, the finalized acquisition of Contessa, a...

Via MarketMinute

Performance

YTD	-18.2%	-18.2%
1 Month	+20.9%	+20.9%
3 Month	-25.2%	-25.2%
6 Month	-45.5%	-45.5%
1 Year	-41.2%	-41.2%

More News

1 Beaten-Down AI Stock to Buy and 1 to Avoid ↗

April 01, 2026

Via The Motley Fool

Recursion Pharmaceuticals (NASDAQ:RXRX) Soars on Q4 Earnings Beat ↗

February 25, 2026

Via Chartmill

Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform

March 31, 2026

From Citeline

Via GlobeNewswire

2 AI Healthcare Stocks to Buy Right Now ↗

March 31, 2026

Via The Motley Fool

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

March 25, 2026

From Recursion Pharmaceuticals

Via GlobeNewswire

Prediction: The "Trough of Disillusionment" Will Create the Best Buying Opportunity for Artificial Intelligence (AI) Stocks in 2026 ↗

March 22, 2026

Via The Motley Fool

Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years. ↗

March 21, 2026

Via The Motley Fool

Can This AI Stock Bounce Back in 2026? ↗

March 08, 2026

Via The Motley Fool

Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!

February 26, 2026

Via AB Newswire

Recursion (RXRX) Q4 2025 Earnings Call Transcript ↗

February 25, 2026

Via The Motley Fool

What's Behind The Jump In Recursion Pharmaceuticals Stock? ↗

February 25, 2026

Via Benzinga

RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ ↗

February 25, 2026

Via Stocktwits

Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

February 25, 2026

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC

February 23, 2026

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

February 23, 2026

From Recursion Pharmaceuticals

Via GlobeNewswire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

February 22, 2026

Via The Motley Fool

NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges ↗

February 19, 2026

Via MarketBeat

Recursion Pharmaceuticals Stock Drops: What's Behind It? ↗

February 18, 2026

Via Benzinga

Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25

February 18, 2026

From Recursion Pharmaceuticals

Via GlobeNewswire

The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot

February 17, 2026

Via MarketMinute

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

February 12, 2026

From Recursion Pharmaceuticals

Via GlobeNewswire

This $4 Stock Could Be Your Ticket to Millionaire Status ↗

February 07, 2026

Via The Motley Fool

Harvard’s PopEVE AI Cracks the Code of Rare Diseases: Ending the ‘Diagnostic Odyssey’ for Millions

February 06, 2026

Via TokenRing AI

Frequently Asked Questions

Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?

Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market

What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 3.434

When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 04/28/26 03:01 PM ET

What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 578.32M

How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Recursion Pharmaceuticals, Inc. - Class A Common Stock has 578M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.